Skip to main content

and
Your search also matched 2 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapy

Include preview-only content
  1. Article

    Open Access

    Safety, antitumor activity, and pharmacokinetics of dostarlimab, an anti-PD-1, in patients with advanced solid tumors: a dose–escalation phase 1 trial

    New immuno-oncology therapies targeting programmed cell death receptor 1 (PD-1) have improved patient outcomes in a broad range of cancers. The objective of this analysis was to evaluate the PK, pharmacodynami...

    Amita Patnaik, Glen J. Weiss, Drew W. Rasco in Cancer Chemotherapy and Pharmacology (2022)

  2. Article

    Open Access

    Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase

    Metastatic breast cancer (mBC) remains incurable and is associated with low survival rates. This study assessed the efficacy and safety of liposomal irinotecan in heavily pretreated patients with mBC, with or ...

    Jasgit C. Sachdev, Pamela Munster in Breast Cancer Research and Treatment (2021)